$1.360
+0.074 (+5.43%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
ALX Oncology Holdings Inc (ALXO) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting ALXO is Strong sell.
ALX Oncology Holdings Inc (ALXO) 20-Day simple moving average is 1.17, while ALX Oncology Holdings Inc (ALXO) share price is $—, making it Sell.
ALX Oncology Holdings Inc (ALXO) 60-Day simple moving average is 1.55, while ALX Oncology Holdings Inc (ALXO) share price is $—, making it Sell.
Technical Analysis for ALXO
AI Technical ALXOAs of 2026-11-03, the technical board for ALX Oncology Holdings Inc (ALXO) reads strong sell: 1 indicators are flashing buy, 8 are indicating sell, and 4 are neutral. Price at $1.15 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 44.215, MACD stands at -0.0368 (Sell), Stochastic %K stands at 65.93, Stochastic %D stands at 77.331 and CCI stands at 35.757.
ALXO trades below the 60-day SMA (1.55) and below the 200-day SMA (1.82). Immediate resistance sits at Classic R1 1.42, then R2 1.61. Support sits at Classic S1 1.03, then S2 0.83.
ALX Oncology Holdings Inc (ALXO) Support & Resistance Level
ALX Oncology Holdings Inc (ALXO) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 44.215 |
| STOCHk_14_3_3 | 65.930 |
| STOCHd_14_3_3 | 77.331 |
| CCI_20 | 35.757 |
| AO_5_34 | 0.047 |
| MOM_10 | -0.040 |
| MACD_12_26_9 | -0.037 |
ALX Oncology Holdings Inc (ALXO) Relative Strength Index (RSI_14) is 44.215, creating a Neutral signal.
ALX Oncology Holdings Inc (ALXO) Stochastic %K is 65.930, creating a Neutral signal.
ALX Oncology Holdings Inc (ALXO) Stochastic %D is 77.331, creating a Neutral signal.
ALX Oncology Holdings Inc (ALXO) CCI_20 is 35.757, creating a Neutral signal.
ALX Oncology Holdings Inc (ALXO) Awesome Oscillator (AO) is 0.047, creating a Buy signal.
ALX Oncology Holdings Inc (ALXO) Momentum (MOM) is -0.040, creating a Sell signal.
ALX Oncology Holdings Inc (ALXO) Moving Average Convergence Divergence (MACD) is -0.037, creating a Sell signal.
ALX Oncology Holdings Inc (ALXO) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.278 | Sell |
| MA_10 | 1.219 | Sell |
| MA_20 | 1.168 | Sell |
| MA_60 | 1.547 | Sell |
| MA_200 | 1.824 | Sell |
| MA_250 | 1.730 | Sell |
ALX Oncology Holdings Inc (ALXO) 5-Day simple moving average is 1.278, while ALX Oncology Holdings Inc (ALXO) share price is $, making it a Sell.
ALX Oncology Holdings Inc (ALXO) 10-Day simple moving average is 1.219, while ALX Oncology Holdings Inc (ALXO) share price is $, making it a Sell.
ALX Oncology Holdings Inc (ALXO) 20-Day simple moving average is 1.168, while ALX Oncology Holdings Inc (ALXO) share price is $, making it a Sell.
ALX Oncology Holdings Inc (ALXO) 60-Day simple moving average is 1.547, while ALX Oncology Holdings Inc (ALXO) share price is $, making it a Sell.
ALX Oncology Holdings Inc (ALXO) 200-Day simple moving average is 1.824, while ALX Oncology Holdings Inc (ALXO) share price is $, making it a Sell.
ALX Oncology Holdings Inc (ALXO) 250-Day simple moving average is 1.730, while ALX Oncology Holdings Inc (ALXO) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.